9 reports

Amenorrhea Global Clinical Trials Review, H##, 2017 Healthcare REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: MAR 2017 LIST OF TABLES LIST OF FIGURES Amenorrhea Global Clinical Trials Review, H##, 2017 outlines clinical trials in Amenorrhea.

  • Genitourinary System Disease
  • Hormones
  • World
  • Product Initiative
  • Repros Therapeutics Inc.

Binocrit (epoetin alfa Zarzio/ Zarxio (filgrastim) Used in therapy area of Hematology. neutropenia after chemotherapy.

  • Hormones
  • World
  • Market Size
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Clinical Trial profile. 71 Trial Title

Proteinuria Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: OCT 2016 LIST OF TABLES LIST OF FIGURES Proteinuria Global Clinical Trials Review, H##, 2016 outlines clinical trials in Proteinuria.

  • Clinical Trial
  • Drug Discovery And Development
  • Hormones
  • World
  • Product Initiative

Filgrastim or Lenograstim or CSF##), Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF##), Interferon Gamma (Immune Interferon or IFNG), Interleukin ## Beta (IL ## Beta or Catabolin or IL##B), Interleukin ## (Cytoki

  • Clinical Trial
  • Drug Discovery And Development
  • Hormones
  • World
  • Product Initiative
  • MENOPAUSAL HOT FLASHES - PIPELINE BY AMGEN INC., H2 2015
  • Menopausal Hot Flashes - Companies Involved in Therapeutics Development

The company' s key products include Neulasta (pegfilgrastim); Neupogen (filgrastim) indicated for cancer treatment; Enbrel (entanercept) for treating rheumatoid arthritis; Epogen (Erythropoietic Stimulating Agents); Aranesp (darbepoetin alfa) to treat anemia associated with chronic kidn

  • Hormones
  • R&D
  • United States
  • World
  • Product Initiative

filgrastim + plerixafor) Rutgers Biomedical and Health Sciences Proteonomix Inc ## Jan 2013 Use of Immune Globulin Intravenous (Human), ##% (IVIG), Plus Rituximab as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting

  • Cytokine
  • Hormones
  • Renal Disease
  • United States
  • World

filgrastim + plerixafor) Rutgers Biomedical and Health Sciences Proteonomix Inc ## Jan 2013 Clinical Trial profile. 2023 Trial Title Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborator(s) Estimated Start Date Actual Start date Estimated Completion Date # of

  • Clinical Trial
  • Genitourinary System Disease
  • Hormones
  • Pharmaceutical
  • World

filgrastim + plerixafor) Rutgers Biomedical and Health Sciences Proteonomix, Inc. ## Jan 2013 Official Title Clinical Trial profile. ## Trial Title Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborator(s) Actual Start date Estimated Completion Date # of Subj

  • Clinical Trial
  • Drug Discovery And Development
  • Hormones
  • Pharmaceutical
  • World
  • MENOPAUSAL HOT FLASHES - PIPELINE BY AMGEN INC., H1 2015
  • Menopausal Hot Flashes - Companies Involved in Therapeutics Development

The company' s key products include Neulasta (pegfilgrastim); Neupogen (filgrastim) indicated for cancer treatment; Enbrel (entanercept) for treating rheumatoid arthritis; Epogen (Erythropoietic Stimulating Agents); Aranesp (darbepoetin alfa) to treat anemia associated with chronic kidn

  • Hormones
  • R&D
  • United States
  • World
  • Product Initiative